Concept

Edoxaban

Summary
Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 415900881 | drug_name = | INN = | type = | image = Edoxaban.svg | width = 275 | alt = | caption = | pronounce = | tradename = Savaysa, Lixiana, Roteas, others | Drugs.com = | MedlinePlus = a614055 | licence_EU = yes | DailyMedID = Edoxaban | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_US = N | pregnancy_US_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATC_prefix = B01 | ATC_suffix = AF03 | legal_AU = | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status = Rx-only | bioavailability = 62%; Tmax 1–2 hours | protein_bound = 55% | metabolism = minimal CES1, CYP3A4/5, hydrolysis, glucuronidation | elimination_half-life = 10–14 hours | excretion = 62% feces, 35% urine | CAS_number_Ref = | CAS_number = 480449-70-5 | PubChem = 10280735 | IUPHAR_ligand = 7575 | DrugBank_Ref = | DrugBank = DB09075 | ChemSpiderID_Ref = | ChemSpiderID = 8456212 | UNII_Ref = | UNII = NDU3J18APO | KEGG_Ref = | KEGG = D09710 | ChEBI_Ref = | ChEBI = 85973 | ChEMBL_Ref = | ChEMBL = | NIAID_ChemDB = | PDB_ligand = | synonyms = DU-176b | IUPAC_name = ''N-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide | C=24 | H=30 | Cl=1 | N=7 | O=4 | S=1 | smiles = CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3CC@HC(=O)N(C)C | StdInChI_Ref = | StdInChI = 1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34)/t13-,15-,17+/m0/s1 | StdInChIKey_Ref = | StdInChIKey = HGVDHZBSSITLCT-JLJPHGGASA-N Edoxaban, sold under the brand name Lixiana''' among others, is an anticoagulant medication and a direct factor Xa inhibitor.
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.